Kazia Therapeutics Begins Clinical Trial of Paxalisib for Advanced Breast Cancer Kazia Therapeutics has initiated patient dosing in a groundbreaking Phase 1b trial of paxalisib, exploring its potential in advanced breast cancer treatment.

Kazia Therapeutics Begins Clinical Trial of Paxalisib for Advanced Breast Cancer #Australia #Sydney #Kazia_Therapeutics #Paxalisib #Advanced_Breast_Cancer